Proliferative potential and K-ras mutation in epithelial hyperplasia of the gallbladder in patients with anomalous pancreaticobiliary ductal union

Cancer

Volumn 83, Issue 2, 1998, Pages 267-275

  Tanno, Satoshi ^a   Obara, Takeshi ^a   Fujii, Tsuneshi ^a   Mizukami, Yusuke ^a   Shudo, Ryushi ^a   Nishino, Noriyuki ^a   Ura, Hitoshi ^a   Klein Szanto, Andres J P ^b   Kohgo, Yutaka ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b FOX CHASE CANCER CENTER   (United States)

Author keywords

Anomalous pancreaticobiliary ductal union; Cell proliferation; Epithelial hyperplasia; Gallbladder; K ras

Indexed keywords

ADULT; AGED; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM HYPERPLASIA; FEMALE; GALLBLADDER CARCINOMA; GALLBLADDER EPITHELIUM; GENE MUTATION; HUMAN; HUMAN TISSUE; MALE; ONCOGENE K RAS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; BILE DUCTS; CARCINOMA; EPITHELIAL CELLS; FEMALE; GALLBLADDER; GALLBLADDER NEOPLASMS; GENES, RAS; HUMANS; HYPERPLASIA; MALE; MIDDLE AGED; MUTATION; PANCREATIC DUCTS; PROGNOSIS; RISK FACTORS;

EID: 0032528214     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980715)83:2<267::AID-CNCR10>3.0.CO;2-R     Document Type: Article

References (41)

1. Babbitt DP, Starshak RJ, Clemett AR. Choledochal cyst: a concept of etiology. Am J Roentgenol 1973;119:57-62.
2. Kimura K, Ohto M, Ono T, Tsuchiya Y, Saisho H, Kawamura K, et al. Congenital cystic dilatation of the common bile duct: relationship to anomalous pancreaticobiliary ductal union. Am J Roentgenol 1977;128:571-7.
3. Wong KC, Lister J. Human fetal development of the hepatopancreatic duct junction: a possible explanation of congenital dilatation of the biliary tract. J Pediatr Surg 1981;16: 139-45.
4. Misra SP, Dwivedi M. Pancreaticobiliary ductal union. Gut 1990;31:1144-9.
5. Kimura K, Ohto M, Saisho H, Unozawa T, Tsuchiya Y, Morita M, et al. Association of gallbladder carcinoma and anomalous pancreaticobiliary ductal union. Gastroenterology 1985; 89:1258-65.
6. Todani T, Tabuchi K, Watanabe Y, Kobayashi T. Carcinoma arising in the wall of congenital bile duct cysts. Cancer 1979;44:1134-41.
7. Todani T, Watanabe Y, Fujii T, Toki A, Uemura S, Koike N, et al. Carcinoma arising from the bile duct in choledochal cyst and anomalous arrangement of the pancreatobiliary ductal union [in Japanese]. Biliary Tract Pancreas 1985;6:525-35.
8. Tanaka K, Nishimura A, Yamada K, Ishibe R, Ishizaki N, Yoshimine M, et al. Cancer of the gallbladder associated with anomalous junction of the pancreatobiliary duct system without bile duct dilatation. Br J Surg 1993;80:622-4.
9. Nagata E, Sakai K, Kinoshita H, Kobayashi Y. The relation between carcinoma of the gallbladder and an anomalous connection between the choledochus and the pancreatic duct. Ann Surg 1985;202:182-90.
10. Sameshima Y, Uchimura M, Muto Y, Maeda J, Tsuchiyama H. Coexistent carcinoma in congenital dilatation of the bile duct and anomalous arrangement of the pancreatico-bile duct: carcinogenesis of coexistent gall bladder carcinoma. Cancer 1987;60:1883-90.
11. Mori K, Nagakawa T, Ohta T, Nakano T, Kayahara M, Kanno M, et al. Association between gallbladder cancer and anomalous union of the pancreaticobiliary ductal system. Hepatogastroenterology 1993;40:56-60.
12. Tokiwa K, Iwai N. Early mucosal changes of the gallbladder in patients with anomalous arrangement of the pancreaticobiliary duct. Gastroenterology 1996;110:1614-8.
13. Hanada K, Itoh M, Fujii K, Tsuchida A, Hirata M, Ishimaru S, et al. Pathology and cellular kinetics of gallbladder with an anomalous junction of the pancreaticobiliary duct. Am J Gastroenterol 1996;91:1007-11.
14. Yamamoto M, Nakajo S, Tahara E, Ito M, Taniyama K, Shimamoto F, et al. Mucosal changes of the gallbladder in anomalous union with the pancreatico-biliary duct system. Pathol Res Pract 1991;187:241-6.
15. Igarashi H. Imaging features of the gallbladder wall in patients with anomalous arrangement of the pancreaticobiliary ductal system [in Japanese]. Tandou 1991;5:517-25.
16. Sato H, Matsuura H, Tahara M, Kono M, Mizushima M, Itoh S, et al. Primary hyperplasia of gallbladder mucosa: report of a probable case with a proposal on the criteria of pathologic diagnosis [in Japanese]. Biliary Tract Pancreas 1985;6:1009-15.
17. Marks F, Bertsch S, Grimm W, Schweizer J. Hyperplastic transformation and tumor promotion in mouse epidermis: possible consequences of disturbances of endogenous mechanism controlling proliferation and differentiation. Carcinogenesis 1978;2:97-116.
18. Argyris TS. Tumor promotion by damage-induced epidermal hyperplasia in the skin of mice. Proc Am Assoc Cancer Res 1979;20:4.
19. Slaga TJ, Scribner JD. Inhibition of tumor initiation and promotion by anti-inflammatory agents. J Natl Cancer Inst 1973;51:1723-5.
20. Cameron R, Lee G, Farber E. Chemical mitogens as effective alternatives to partial hepatectomy in the new model for the sequential analysis of hepatocarcinogenesis. Proc Am Assoc Cancer Res 1978;19:56.
21. Albores-Saavedra J, Alcántra-Vazquez A, Cruz-Ortiz H, Herrera-Goepfert R. The precursor lesions of invasive gallbladder carcinoma: hyperplasia, atypical hyperplasia and carcinoma in situ. Cancer 1980;45:919-27.
22. Elfving G, Lehtonen T, Teir H. Clinical significance of primary hyperplasia of gallbladder mucosa. Ann Surg 1967;165: 61-9.
23. Kawai K, Serizawa A, Hamana T, Tsutsumi Y. Heat-induced antigen retrieval of proliferating cell nuclear antigen and p53 protein in formalin-fixed, paraffin-embedded sections. Pathol Int 1994;44:759-64.
24. Weidner N, Moore DH, Vartanian R. Correlarion of Ki-67 antigen expression with mitotic index and tumor grade in breast carcinomas using the novel "paraffin"-reactive MIB 1 antibody. Hum Pathol 1994;25:337-42.
25. Levi S, Urbano-Ispizua A, Gill R, Thomas DM, Gilbertson J, Foster C, et al. Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique. Cancer Res 1991;51:3497-502.
26. Berrozpe G, Schaeffer J, Peinado MA, Real FX, Perucho M. Comparative analysis of mutations in the p53 and K-ras genes in pancreatic cancer. Int J Cancer 1994;58:185-91.
27. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A 1977; 74:5463-7.
28. Albores-Saavedra J, Defortuna SM, Smothermon WE. Primary papillary hyperplasia of the gallbladder and cystic and common bile duct. Hum Pathol 1990;21:228-31.
29. Celoria GC, Rodriguez Otero JC, Proske SA, Vallilengua C. Papillary hyperplasia and cholesterolosis of the gallbladder. Med Lav 1994;54:31-4.
30. Gerdes J, Lemke H, Baisch H, Wacker H-H, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984;133:1710-5.
31. Ames BN. Mutagenesis and carcinogenesis: endogenous and exogenous factors. Environ Mol Mutagen 1989;14:66-77.
32. Ames BN. Endogenous oxidative DNA damage, aging, and cancer. Free Radic Res Commun 1989;7:121-8.
33. Fraga CG, Shigenaga MK, Park JW, Degan P, Ames BN. Oxidative damage during aging: 8-hydroxy-2′-deoxyguanosine in rat organ DNA and urine. Proc Natl Acad Sci U S A 1990;87:4533-7.
34. Reveille RM, Van Stiegmann G, Everson GT. Increased secondary bile acids in a choledochal cyst: possible role in biliary metaplasia and carcinoma. Gastroenterology 1990;99: 525-7.
35. Qian D, Kinouchi T, Kunitomo K, Kataoka K, Matin MA, Akimoto S, et al. Mutagenicity of the bile of dogs with an experimental model of an anomalous arrangement of the pancreaticobiliary duct. Carcinogenesis 1993;14: 743-7.
36. Watanabe M, Asaka M, Tanaka J, Kurosawa M, Kasai M, Miyazaki T. Point mutation of K-ras gene codon 12 in biliary tract tumors. Gastroenterology 1994;107:1147-53.
37. Ohashi K, Tsutsumi M, Nakajima Y, Nakano H, Konishi Y. Ki-ras point mutations and proliferation activity in biliary tract carcinomas. Br J Cancer 1996;74:930-5.
38. Imai M, Hoshi T, Ogawa K. K-ras codon 12 mutations in biliary tract tumors detected by polymerase chain reaction denaturing gradient gel electrophoresis. Cancer 1994; 73:2727-33.
39. Matsubara T, Sakurai Y, Sasayama Y, Hori H, Ochiai M, Funabiki T, et al. K-ras point mutations in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction. Cancer 1996;77:1752-7.
40. Wistuba II, Gazdar AF, Roa I, Albores-Saavedra J. p53 protein overexpression in gallbladder carcinoma and its precursor lesions: an immunohistochemical study. Hum Pathol 1996;27:360-5.
41. Wituba II, Sugio K, Hung J, Kishimoto Y, Virmani AK, Roa I, et al. Allele-specific mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile. Cancer Res 1995; 55:2511-5.